Association of patients' sex with treatment outcomes after intravesical bacillus Calmette-Guérin immunotherapy for T1G3/HG bladder cancer - D'Andrea, David (Medical University of Vienna. Department of Urology) ; Soria, F. (University of the Studies of Turin. Division of Urology.) ; Grotenhuis, A.J. (Radboud University Medical Centre. Department of Urology) ; Cha, E.K. (Memorial Sloan Kettering Cancer Center Department of Urology) ; Malats, Núria (Centro Nacional de Investigaciones Oncológicas) ; Di Stasi, S. (Policlinico Tor Vergata-University of Rome. Department of Urology.) ; Joniau, Steven (University Hospitals Leuven. Department of Urology.) ; Cai, T. (Santa Chiara Hospital. Department of Urology) ; van Rhijn, B.W.G. (The Netherlands Cancer Institute (Amsterdam, Països Baixos)) ; Irani, J. (University of Poitiers. Department of Urology.) ; Karnes, J. (Mayo Clinic. Department of Urology) ; Varkarakis, J. (University of Athens. Department of Urology) ; Baniel, J. (Rabin Medical Centre. Department of Urology) ; Palou, Juan (Institut d'Investigació Biomèdica Sant Pau) ; Babjuk, Marek (University of Praha. Department of Urology.) ; Spahn, M. (University Hospital of Wuerzburg. Department of Urology) ; Ardelt, P. (Universitätsklinik Freiburg. Department of Urology) ; Colombo, Renzo (Università Vita Salute. Department of Urology) ; Serretta, V. (University of Palermo. Department of Surgical) ; Dalbagni, G. (Memorial Sloan Kettering Cancer Center. Department of Urology) ; Gontero, Paolo (Università degli Studi di Torino) ; Bartoletti, R. (University of Pisa. Department of Translational Research and New Technologies) ; Larré, S. (CHU de Reims. Department of Urology) ; Malmström, Per-Uno (Uppsala University (Uppsala, Suècia)) ; Sylvester, R. (European Association of Urology Non-Muscle Invasive Bladder Cancer Guidelines Panel) ; Shariat, S.F. (European Association of Urology Research Foundation)